Teichoic Acid: Structure, Types, and Functions

Many gram-positive bacteria have acidic components called teichoic acids embedded in their cell wall. Teichoic acids were discovered in 1958 by Armstrong and co-authors.

Figure: Gram Positive cell wall with Teichoic acid

The term teichoic acid encompasses a diverse family of cell surface glycopolymers containing phosphodiester-linked polyol repeat units. Teichoic acids are fibers of glycerol phosphate (glycerol teichoic acid) or ribitol phosphate (ribitol teichoic acid).

Teichoic acids are located in the outer layer of certain Gram-positive bacteria (such as Staphylococci, Streptococci, Lactobacilli, and Bacillus spp). So far teichoic acids have not been present in Gram-negative Bacteria.

Why teichoic acids matter?

Teichoic acid is one of those topics that appears in every microbiology textbook, gets tested in every exam, and yet leaves students wondering: "Why does this obscure cell wall polymer deserve a whole lecture?"

Here is the honest answer — three reasons teichoic acid is genuinely important for a medical professional to understand:

1. Gram-positive sepsis kills patients — and teichoic acid is the trigger When we think of bacterial sepsis, we often think of gram-negative endotoxin (LPS). But gram-positive bacteria — Staphylococcus aureus, Streptococcus pneumoniae, Enterococcus — are equally common causes of life-threatening sepsis. The inflammatory mediator responsible for gram-positive septic shock is primarily lipoteichoic acid (LTA) — which triggers TLR2 on macrophages and monocytes in the same way LPS triggers TLR4. A student who understands this can immediately explain why a patient with gram-positive bacteraemia develops the same clinical picture of fever, hypotension, and cytokine storm as a patient with gram-negative sepsis — despite having no LPS.

2. Teichoic acid determines where S. aureus lives — and therefore who gets infected S. aureus colonises the anterior nares (nostrils) of approximately 30% of healthy adults. The reason it prefers the nose over other body surfaces is largely due to wall teichoic acid — specifically, the ribitol-phosphate WTAs of S. aureus bind directly to a protein called SDRP on nasal epithelial cells. This adhesion is the first step in nasal colonisation, and nasal colonisation is the primary risk factor for subsequent S. aureus infection (surgical site infections, MRSA bacteraemia). Blocking WTA-mediated adhesion is therefore a genuine infection prevention strategy.

3. Teichoic acids are emerging antibiotic drug targets The enzymes that synthesise wall teichoic acids (particularly the enzyme TarO, which catalyses the first committed step in WTA biosynthesis in S. aureus) are essential for bacterial survival in the host — and importantly, they have no human homologues. This makes them highly selective targets for novel antibiotics. Compounds that inhibit WTA biosynthesis are in active development as treatments for MRSA, where conventional antibiotic options are limited.

Types of Teichoic Acids

1. Lipoteichoic acids (LTAs): Teichoic acids that are covalently linked to the lipid in the cytoplasmic membrane.
2. Wall teichoic acids (WTAs): Teichoic acids that are covalently attached to muramic acid in the wall peptidoglycan.

Figure: Wall Teichoic acid and Lipoteichoic acid

Wall teichoic acids are intimately involved in many aspects of cell division and are essential for maintaining cell shape in rod-shaped organisms. WTAs are required for ß-lactam resistance in methicillin-resistant S. aureus(MRSA), and they modulate susceptibility to cationic antibiotics in several organisms.

The analogy that makes WTA vs LTA location unforgettable

Think of the gram-positive cell wall as a brick wall with electrical wiring running through it.

• The peptidoglycan is the brick structure — the rigid framework
• The wall teichoic acids (WTAs) are the wiring embedded within the bricks — covalently attached to the peptidoglycan itself, running through the wall, with their ends protruding from the outer surface
• The lipoteichoic acids (LTAs) are the wiring anchored at the electrical panel (the plasma membrane) — rooted in the membrane lipid bilayer and extending outward through the peptidoglycan to the surface

Both types of "wiring" carry the same negative charge (their electrical current, so to speak), but they are anchored at different points. This physical arrangement explains why they have somewhat different functions — WTAs interact more with the external environment (phage receptors, adhesion), while LTAs interact more with the plasma membrane and regulate internal processes (autolysis, ion transport).

Clinical and Medical Significance of Teichoic Acids

1. Gram-positive septic shock — LTA as the trigger

When gram-positive bacteria are killed in the bloodstream — whether by antibiotics or host immune cells — they release their cell wall components, including large quantities of lipoteichoic acid. LTA binds to TLR2 (Toll-like receptor 2) on the surface of macrophages and monocytes, triggering the same cytokine cascade (TNF-α, IL-1, IL-6) that LPS triggers through TLR4.

This means the clinical picture of gram-positive septic shock — high fever, hypotension, tachycardia, risk of multi-organ failure — is mediated by LTA in the same way gram-negative septic shock is mediated by LPS.

The important nuance: LTA is generally considered less potent than LPS as an inflammatory stimulus — it requires approximately 1,000 times higher concentrations to produce equivalent cytokine release. This partly explains why gram-positive sepsis, while serious, tends to have a somewhat lower case fatality rate than gram-negative sepsis. But at the concentrations released during a bloodstream infection, LTA is more than sufficient to produce life-threatening systemic inflammation.

2. S. aureus nasal colonisation and MRSA infection risk

The anterior nares are the ecological niche of Staphylococcus aureus. Approximately:

• 30% of healthy adults are persistent nasal carriers
• 30% are intermittent carriers
• 40% are non-carriers

This colonisation is not random — it depends on ribitol-phosphate wall teichoic acids on the S. aureus surface binding to specific receptors on nasal epithelial cells. Non-carrier individuals have nasal microbiota that competitively exclude S. aureus partly by competing for the same adhesion sites.

Why this matters clinically: Nasal carriage of S. aureus (especially MRSA) is the single most important risk factor for subsequent S. aureus infection. MRSA surgical site infection rates are substantially higher in patients colonised with nasal MRSA at the time of surgery. This is why preoperative MRSA nasal decolonisation with mupirocin nasal ointment (which inhibits bacterial protein synthesis and reduces nasal carriage) is recommended before high-risk procedures like cardiac surgery and joint replacement. Understanding that WTA drives this colonisation is understanding why this prevention strategy targets the nose specifically.

3. D-alanine modification and antibiotic resistance

The teichoic acid backbone can be modified by the addition of D-alanine residues by a set of enzymes encoded by the dlt operon (DltA, DltB, DltC, DltD). These D-alanine residues reduce the overall negative charge of the teichoic acid and the cell surface.

Why this matters: Many host antimicrobial peptides (defensins, cathelicidins) work by being attracted to the negatively charged bacterial surface — they are cationic (positively charged) and bind electrostatically to the anionic bacteria, then insert into and disrupt the cell membrane. By adding D-alanine to teichoic acids, bacteria reduce the negative charge of their surface, reducing electrostatic attraction and making themselves significantly more resistant to these host antimicrobial peptides.

Bacteria with mutations in the dlt operon (no D-alanine incorporation) are:

• More susceptible to cationic antimicrobial peptides (defensins)
• More susceptible to vancomycin (slightly)
• Less virulent in animal infection models

This resistance mechanism is one reason gram-positive pathogens can survive in host environments that should be lethal — tissues and body fluids are rich in antimicrobial peptides.

4. Bacteriophage receptor

Wall teichoic acids serve as the primary receptor for many bacteriophages that infect gram-positive bacteria. The phage tail fibres recognise and bind to the specific WTA structure of their host bacterium. This specificity is so precise that the same bacterial species with different WTA structures (due to different glycosylation patterns) can be completely resistant to a phage that infects the parent strain.

Why this matters:

• Phage typing — historically used for S. aureus epidemiological typing — was entirely based on the specificity of phage-WTA binding
• Phage therapy (using bacteriophages to treat antibiotic-resistant infections) depends on matching the correct phage to the WTA structure of the target bacterium
• Anti-WTA strategies that modify or block WTA synthesis can sensitise normally phage-resistant bacteria to phage killing — a potential synergistic therapeutic approach for MRSA

5. Cation regulation and cell physiology

The high negative charge of teichoic acids serves as a cation reservoir at the cell surface — they bind and concentrate divalent cations (Ca²⁺, Mg²⁺) for regulated transport into the cell. These cations are essential cofactors for many membrane enzymes, including the autolysins that remodel peptidoglycan during cell division.

Teichoic acids also regulate autolysis — the controlled breakdown of peptidoglycan that is essential for cell wall remodelling during growth and division. If teichoic acid synthesis is inhibited, autolytic activity becomes dysregulated, leading to aberrant cell wall structure and eventually cell death. This is one reason why WTA biosynthesis inhibitors are being explored as antibiotics — inhibiting WTA indirectly disrupts autolysis and kills the bacterium through a mechanism entirely different from beta-lactams or glycopeptides.

Structure of Teichoic Acid

TAs are glycopolymers rich in phosphates present in the peptidoglycan layers of Gram-positive bacteria (pathogenic and nonpathogenic). The structure of teichoic acid varies based on its type. Below is a brief description of the wall- and lipo-teichoic acid structure.

Structure of Wall Teichoic Acid (WTA)

In WTAs, the anionic glycopolymers attach covalently to peptidoglycan by a phosphodiester linkage to the C6 hydroxyl of the N-acetyl muramic acid sugars. These form 60% of the total cell wall of Gram-positive organisms.

Figure: Structure of Teichoic acid from Micrococcaceae

The chemical structures of WTAs vary in different organisms. However, the typical structure comprises ManNAc (β1→4)GlcNAc disaccharide with one of the three glycerol phosphates attached to the C4 hydroxyl of the ManNAc residue. A much longer chain of glycerol- or ribitol-phosphate repeats (the main chain) follows this chain. For example, Staphylococcus aureusstrains primarily have poly (ribitol phosphate), but Bacillus subtilismay have both poly(glycerol phosphate) or poly (ribitol phosphate), depending on the strains.

The tailoring of hydroxyls on the glycerol- or ribitol phosphate repeats occur with cationic D-alanine esters and monosaccharides like glucose or N-acetylglucosamine. The presence of WTAs and the particular modifications found on the organisms profoundly affect the physiology of Gram-positive organisms, their interactions with hosts, and their susceptibility to antibiotics.

Structure of Lipoteichoic Acid (LTA)

Figure: Lipoteichoic acid

LTA are the macro amphiphiles possessing alditol phosphate residues in their hydrophilic moiety. There are two types of present: poly(glycerol phosphate) and poly-(ribitol phosphate). The poly(glycerol phosphate) is the standard type. A glycolipid (in most cases) forms the hydrophobic moiety of the LTA—the hydrophilic part links to the glycolipid by a phosphodiester bridge. The glycolipid anchors all the molecules in the cytoplasmic membrane.

WTA vs LTA — Quick Reference

How to Learn and Remember Teichoic Acids

The calibration: this is a theory-heavy topic

The difficulty with teichoic acid is not procedural — there is no bench technique to learn, no staining to perform. The difficulty is purely motivational: why memorise the structure of an obscure cell wall polymer? The three clinical stories below address that directly.

One sentence that captures the entire clinical relevance

"Teichoic acid is to gram-positive bacteria what LPS is to gram-negative — it mediates colonisation, drives inflammation in sepsis, and its synthesis enzymes are the next frontier of MRSA drug targets."

Three clinical stories that make teichoic acid memorable

Story 1 — The pre-op MRSA swab A patient is admitted for elective hip replacement. Routine pre-operative MRSA screening swabs the anterior nares. The swab comes back positive — MRSA nasal carriage. Surgery is postponed for 5 days while the patient applies mupirocin nasal ointment twice daily to decolonise the nose. Why the nose? Because S. aureus WTA binds specifically to nasal epithelial cell receptors. Why mupirocin? Because it kills the colonising bacteria, removing the source. Every MRSA decolonisation protocol in every hospital in the world exists because of the teichoic acid-mediated nasal adhesion of S. aureus.

Story 2 — The septic patient who "should" have LPS A junior doctor sees a patient in septic shock with high fever, hypotension, and rising inflammatory markers. Blood cultures grow gram-positive cocci in clusters — S. aureus bacteraemia. The junior asks: "But I thought septic shock was caused by endotoxin — shouldn't this be gram-negative?" The answer is lipoteichoic acid — the gram-positive equivalent of endotoxin. TLR2, not TLR4. Same cytokine storm, different trigger, similar clinical picture. Understanding LTA is understanding why gram-positive sepsis is just as dangerous as gram-negative.

Story 3 — The MRSA phage therapy dilemma A patient with chronic MRSA osteomyelitis (bone infection) has failed multiple antibiotic courses. The clinician considers experimental phage therapy — using bacteriophages to kill the MRSA. A phage is selected that kills laboratory MRSA strains perfectly. But when applied to the patient's own MRSA isolate, it fails completely. The reason: the patient's MRSA strain has a different WTA glycosylation pattern than the laboratory strain — the phage tail fibres cannot bind the patient's WTA. A new phage with matching specificity must be found. This is the real challenge of phage therapy — WTA variation means a single phage rarely covers all strains of the same species.

Key exam facts in one table

References

1. Madigan, M. T., Bender, K. S., Buckley, D. H., Sattley, W. M., & Stahl, D. A. (2018). Brock Biology of Microorganisms (15th ed.). Pearson.
2. Tille, P. M. (2017). Bailey & Scott's Diagnostic Microbiology (14th ed.). Mosby Elsevier.
3. Brown, S., Santa Maria, J. P., & Walker, S. (2013). Wall teichoic acids of gram-positive bacteria. Annual Review of Microbiology, 67, 313–336. https://doi.org/10.1146/annurev-micro-092412-155620
4. Weidenmaier, C., & Peschel, A. (2008). Teichoic acids and related cell-wall glycopolymers in Gram-positive physiology and host interactions. Nature Reviews Microbiology, 6(4), 276–287. https://doi.org/10.1038/nrmicro1861